CMANY
MDT icon

Capital Management Associates (New York)’s Medtronic MDT Stock Holding History

Capital Management Associates (New York)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,000
Closed -$935K – 74
2020
Q3 		$935K Hold
9,000
– – 1.23% 32
2020
Q2 		$825K Hold
9,000
– – 1.16% 35
2020
Q1 		$812K Buy
+9,000
New +$957K 1.47% 25

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Management Associates (New York)'s MDT Position: Q4 2020 in Review

Capital Management Associates (New York) sold out of Medtronic (MDT) in Q4 2020, closing a stake of 9,000 shares — an estimated $935K sold.

Capital Management Associates (New York) first reported a position in MDT in Q1 2020 and held it in 3 quarters. The position peaked at $935K in Q3 2020. 1,958 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Capital Management Associates (New York) reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Capital Management Associates (New York) sold 9,000 Medtronic shares in Q4 2020, an estimated $935K.
  • Capital Management Associates (New York) first reported a position in Medtronic in Q1 2020 and held it in 3 quarters.
  • Capital Management Associates (New York)'s Medtronic position peaked at $935K in Q3 2020.
  • 1,958 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Capital Management Associates (New York)'s 13F filing for Q4 2020, filed 9 Feb 2021.